ALZHEON

Alzheon is a clinical-stage biotechnology company focused on womanchild brain health, memory, and aging, developing transformative treatments for Alzheimer’s disease and other neurodegenerative disorders. They are building a pipeline of innovative drugs to improve the lives of patients by preventing the cognitive and functional decline associated with neurodegeneration. They have a distinct ability to make success advances in the challenging field of therapeutics for Alzheimer’s and other neurodegenerative disorders.

ALZHEON

Social Links:

Twitter

Industry:

Biotechnology Clinical Trials Health Care Therapeutics

Founded:

2013-01-01

Address:

Lexington, Massachusetts, United States

Country:

United States

Website Url:

http://www.alzheon.com

Total Employee:

11+

Status:

Active

Contact:

+1 857 214-7242

Email Addresses:

[email protected]

Total Funding:

136.45 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network

Similar Organizations

imaginab-logo

ImaginAb

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.

Current Advisors List

jean-pierre-garnier_image

Jean-Pierre Garnier Chairman of the Board @ Alzheon
Board_member

scott-minick_image

Scott Minick Member of Board of Directors @ Alzheon
Board_member
2012-01-01

Current Employees Featured

ken-mace_image

Ken Mace
Ken Mace Chief Financial Officer @ Alzheon
Chief Financial Officer
2021-01-01

martin-tolar_image

Martin Tolar
Martin Tolar Founder, President & CEO @ Alzheon
Founder, President & CEO
2013-01-01

not_available_image

John Hey
John Hey Chief Scientific Officer @ Alzheon
Chief Scientific Officer

adem-albayrak_image

Adem Albayrak
Adem Albayrak Head of Operations @ Alzheon
Head of Operations
2021-01-01

not_available_image

Patrick Kesslak
Patrick Kesslak VP Clinical Development & Medical Affairs @ Alzheon
VP Clinical Development & Medical Affairs
2022-04-01

susan-flint_image

Susan Flint
Susan Flint Vice President of Clinical Operations @ Alzheon
Vice President of Clinical Operations
2022-04-01

not_available_image

Erwan de Naurois
Erwan de Naurois VP of Finance @ Alzheon
VP of Finance
2022-04-01

Founder

martin-tolar_image

Martin Tolar

Investors List

national-institute-on-aging_image

Key Employee Changes

Date	New article
2022-04-14	Alzheon Appoints Susan Flint as Vice President of Clinical Operations, Patrick Kesslak, PhD, as Vice President of Clinical Development & Medical Affairs, and Erwan de Naurois as Vice President of F...
2021-09-13	Alzheon Appoints Adem Albayrak as Head of Operations and Earvin Liang, PhD, as Vice President of Clinical Development

Official Site Inspections

http://www.alzheon.com Semrush global rank: 2.92 M Semrush visits lastest month: 5.58 K

Host Informations
Whois Informations

Loading ...